Medical device company Occlutech Holding AG, one of the world?s leading providers of minimally invasive structural heart disease devices, announces the election of four new members to the board
Occlutech Holding AG ( Occlutech ) today announces that Marianne Dicander Alexandersson, Mette-Marie Harild, Helena Levander, and Michel Lussier have been elected as members of the Board of Directors of Occlutech. Marianne Dicander Alexandersson will be nominated as the Chair of the Board of Directors of Occlutech at the Annual General Meeting on 18 June 2021. We are delighted to welcome Marianne, Mette-Marie, Helena, and Michel to Occlutech s board. Their collective management and industry experience will be of utmost value to Occlutech as we continue on our exciting journey to drive the development of world leading products, grow revenue and expand further geographically, said Sabine Bois, Chief Executive Officer of Occlutech.
Neurescue Announces Appointment of Medtronic Veteran Mette-Marie Harild to Company s Board of Directors
Ms. Harild Brings Over 30 Years of Medical Device and Pharmaceutical Industry Experience
Neurescue, a clinical-stage medical device company bringing to market the world s first computer-aided balloon catheter for aortic occlusion, today announced that medical device industry veteran Mette-Marie Harild has been appointed to the Neurescue board of directors. Most recently the regional vice president of Medtronic s largest sub-region in Europe, Middle East and Africa (EMEA), Ms. Harild brings significant medical device experience to the team. I am thrilled to join the board of directors at Neurescue to help advance its next-generation balloon catheter technology in development, which has the potential to save the lives of the millions of people worldwide suffering from cardiac arrest each year, said Mette-Marie Harild. There has been little innovation in the treatment approach